A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia

NCT00604279 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

452

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone palmitate (R092670)
DRUG: Risperidone

Sponsor

Xian-Janssen Pharmaceutical Ltd.